News for hackers. Stuff that matters.
Re:ADHD drug treatment and risk of negative events and outcomes by fossuser on Friday August 15, 2025 @05:28PM (#44917468)
My hypothesis about this for a long time has been stimulants help everyone be more productive (with some tradeoffs) and ADHD is kind of a weakly differentiated diagnosis that could apply to most people.

Probably something like this was lost when people stopped smoking, obviously beneficial for health - but a huge amount of the public was taking stimulants regularly via nicotine until relatively recently.

Re:ADHD drug treatment and risk of negative events and outcomes by Spooky23 on Friday August 15, 2025 @06:30PM (#44918032)
That’s a good point on the nicotine.

I found out that i have ADHD through a process of dealing with a hearing issue - I have something called auditory processing disorder (APD), which means while I have excellent hearing, my brain has difficulty processing speech in high noise environments, especially with multiple people or frequencies that correlate to women. ADHD and autism spectrum disorders are highly correlated with it.

A friend who is an audiologist was out with me at an event and basically spotted the adaptations that I had adopted subconsciously over my life (I’m in my 40s). I then got tested and confirmed. It’s likely a result of many consecutive ear infections I had as a kid.

When reading up on APD, the literature describes stories of various people… and it was like looking back on a story of my life. The ADHD correlation is thought to be related because of the way the brain develops (or doesn’t) in the presence or absence of stimuli.

I say this because it would be easy to dismiss my scenario. By most measurements I’m successful and doing great. But had I known or maybe been treated in the past, certain difficult aspects of my life would have likely been managed better or avoided. Brains are complex, and it’s important not to dismiss that problems that people have.

Re:ADHD drug treatment and risk of negative events and outcomes by mrexroad on Friday August 15, 2025 @08:20PM (#44918757)
Clinically ADHD and suspected APD here. I also have excellent hearing in both ears (20k+ hz), but I’m shit at understanding conversations in noisy environments… especially if my wife is speaking. Her voice is markedly harder for me to process than other people’s when there’s background noise. She used to assume I was being ADHD and not paying attention, etc, and get frustrated, but after years of me visibly focusing on her with unreasonable intensity while listening, she started accepting it. It’s always ironic that my hearing is usually noticeably better than any friends or family (both in frequency range and noticing sounds), but I’m often the only one who can’t fully follow conversations at a restaurant/bar/conference/etc.
Re:ADHD drug treatment and risk of negative events and outcomes by Spooky23 on Friday August 15, 2025 @09:53PM (#44919390)
Yeah that’s remarkably similar to my experience. The only surprise is that my hearing was excellent — all of those punk shows in the 90s didn’t damage my hearing!

If it bugs you, a good audiologist or instrumentation specialist can measure the frequencies impacted and mitigate it with hearing aids. I tried it, and i would best describe it like transitioning from 1080p to 4k. The gotcha is the hearing aids are expensive and it is difficult to get a diagnosis that insurance will cover as it’s technically not a hearing loss.

Re:ADHD drug treatment and risk of negative events and outcomes by kayodelycaon on Saturday August 16, 2025 @09:04AM (#44923032)
Same. Excellent hearing but I can’t follow conversations in noisy places. I only catch every other word. It’s like my brain isn’t filtering out the noise in real time so it just stops hearing.

Annoyingly, this can also affect video calls when people don’t speak clearly.

Re:ADHD drug treatment and risk of negative events and outcomes by spangry on Saturday August 16, 2025 @01:37AM (#44920487)
Pretty sure that's what I have too (and am diagnosed ADHD). I used to complain to my Mum that I couldn't hear what people were saying on the bus back home from school. She took me to get a hearing test and it turns out I have bat-like hearing. I'm just not able to seperate out speech from background noise - noisy restaurants and bars are a nightmare.
Re:ADHD drug treatment and risk of negative events and outcomes by rrrrrrrrrrrryan on Friday August 15, 2025 @07:53PM (#44918597)
> a huge amount of the public was taking stimulants regularly

Anecdotally, 100mg of caffeine combined with 200mg of L-theanine makes me maybe 25% as productive as I am on 5mg of Adderall, which is actually enough for me to function most days.

Re:ADHD drug treatment and risk of negative events and outcomes by 0xCMP on Friday August 15, 2025 @05:48PM (#44917645)
I've also heard something similar. That maybe the reason so many are diagnosed today[0] is they were self-medicating via smoking.

[0]: Which requires it to be affecting your life -- NOT that you actually do or don't have it and are dealing with it okay. Diagnostic criteria is that it must be hindering you in a job/school/relationships/etc.

Re:ADHD drug treatment and risk of negative events and outcomes by enneff on Friday August 15, 2025 @06:37PM (#44918095)
The science doesn’t support your hypothesis btw.
Re:ADHD drug treatment and risk of negative events and outcomes by jasonfarnon on Friday August 15, 2025 @07:38PM (#44918513)
Meaning what? All those college kids who took a friend's ritalin prescription to complete a term paper could have done just as well without it? I'm skeptical. Some of us wouldn't have even done the term paper without it, or would have mailed it in. I tend to think of it as little different than steroids. Maybe there's a bigger boost for some individuals than others, but the boost is probably across the board.
Re:ADHD drug treatment and risk of negative events and outcomes by yosame on Friday August 15, 2025 @08:33PM (#44918847)
There was a study where they tested the effects of ADHD meds on test performance and perceived performance. It found that stimulants increased perceived performance for everyone, but actual test scores were only improved for people with ADHD.

This is a good overview of the literature: https://www.frontiersin.org/journals/neuroscience/articles/1...

Re:ADHD drug treatment and risk of negative events and outcomes by fossuser on Saturday August 16, 2025 @09:34AM (#44923272)
I’m willing to update, but a lot of “science” is bullshit.
Re:ADHD drug treatment and risk of negative events and outcomes by brikym on Friday August 15, 2025 @06:16PM (#44917902)
It's a performance enhancing drug for a lot of people. So many of my colleagues are on it.
Re:ADHD drug treatment and risk of negative events and outcomes by thirdacc on Friday August 15, 2025 @08:54PM (#44918975)
>My hypothesis about this for a long time has been stimulants help everyone be more productive (with some tradeoffs)

Of course they do. They're stimulants, that's what they do. Some people just need them to be closer to normal, or whatever's considered normal in post-Industrial society. Modafinil promotes wakefulness in everyone, not just narcolpetics. Anxiolytics calm down everyone, not just the anxious, and psilocybin makes everyone feel euphoric, not just the depressed. It would be weird if stimulants only had an effect of ADHD patients.

> and ADHD is kind of a weakly differentiated diagnosis that could apply to most people.

I don't think we really understand it yet, but it's not something most people have. As the article mentions, people ADHD have a higher rate of transportation accidents, lower life expectancy, higher crime rates, higher addiction rates, etc. The differences show up in brain scans, performance tests, genetic biomarkers, heritability/twin studies, etc. Whether you think of it as a disability, or brain type, or whatever - ADHD is something real.

> Probably something like this was lost when people stopped smoking, obviously beneficial for health - but a huge amount of the public was taking stimulants regularly via nicotine until relatively recently.

Yes, and this is possibly why 35-55% of adults with ADHD smoke today, compared to 19% of the population. Studies have shown that nicotine is helpful for everyone but particularly helpful for those with ADHD. Nicotine-derived formulations are still being explored.

Re:ADHD drug treatment and risk of negative events and outcomes by ttul on Friday August 15, 2025 @10:46PM (#44919677)
ADHD is a well-established, highly heritable neurodevelopmental disorder. Large-scale twin, genetic, neuroimaging, and longitudinal studies consistently show distinct brain, behavioral, and outcome differences compared to the general population. While we don’t yet understand every mechanism or subtype, the condition is robustly characterized and recognized by all major medical bodies. The World Federation of ADHD International Consensus Statement concludes: “ADHD is a genuine neurodevelopmental disorder with a well-documented genetic and neurobiological basis” and emphasizes that claims to the contrary are “contrary to scientific evidence and risk causing harm” [1].

Medical and psychological professionals are VERY confident that ADHD is a real condition—on par with the confidence they have in diagnoses like major depressive disorder or generalized anxiety disorder.

Across psychiatry, ADHD, depression, and anxiety are all among the best-documented psychiatric conditions. There is more skepticism about disorders with fuzzier boundaries (e.g., “personality disorders” or “internet addiction”), but ADHD is NOT in that category.

I believe ADHD is stigmatized in our culture because our modern world makes us all feel distracted at times; therefore, it seems like people with the diagnosis are perhaps getting a “free ride” by blaming their poor behavior on a “condition”. But ADHD is so much more than just having a hard time focusing because of social media and phones. It manifests as a spectrum of extreme challenges that lead over time to sufferers having a significantly harder time navigating life than people without ADHD.

Merely having a hard time concentrating does not make you an ADHD candidate. You must experience a range of symptoms that interfere materially in multiple areas of life.

⸻

Reference

[1] Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., … Wang, Y. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022

Re:ADHD drug treatment and risk of negative events and outcomes by StevenWaterman on Saturday August 16, 2025 @09:32AM (#44923263)
> It would be weird if stimulants only had an effect of ADHD patients

One example of this actually happening is the concept of a "stimulant nap" in people with ADHD, where stimulants actually make them sleepier. Also manifesting as "I tried coke once, it didn't do anything, I just felt sleepy"

Terrible source but it's a pretty common thing: https://www.reddit.com/r/ADHD/comments/hkkyjl/you_know_your_...

Re:ADHD drug treatment and risk of negative events and outcomes by agency on Saturday August 16, 2025 @10:04AM (#44923546)
I find the claim (repeated verbatim in some of the comments here) that people with ADHD process stimulants differently particularly specious. Are there any medical studies/not-reddit threads that suggest anything like this?
Re:ADHD drug treatment and risk of negative events and outcomes by StevenWaterman on Saturday August 16, 2025 @10:33AM (#44923791)
Essentially the idea is that there is an "optimal" amount of alertness (inverted U curve). People with ADHD start below the optimal point, and stimulants move them up towards the optimal point. People without ADHD are typically closer to the optimal point, and stimulants move them past it.

Someone with ADHD taking a large dose will therefore feel the same as someone without ADHD taking a small(er) dose.

Methylphenidate improves sleep in people with ADHD: https://pmc.ncbi.nlm.nih.gov/articles/PMC2276739/

> Compared to [non-adhd] controls untreated [adhd] patients showed increased nocturnal activity, reduced sleep efficiency, more nocturnal awakenings and reduced percentage of REM sleep. Treatment [of those with adhd] with methylphenidate resulted in increased sleep efficiency as well as a subjective feeling of improved restorative value of sleep.

I can't find a corresponding paper studying the effect of stimulants on sleep in healthy adults. I would assume it hasn't been studied because it's common knowledge and it's not worth the risk of making healthy people take stimulants. I also don't think that's the part you were disputing.

Re:ADHD drug treatment and risk of negative events and outcomes by lazide on Sunday August 17, 2025 @11:04AM (#44932123)
It’s called the ‘paradoxical calming effect’. Here is a nature article on it [https://www.nature.com/articles/s41598-022-07029-2].

Here is more detailed data [https://www.researchgate.net/publication/45708101_Role_of_Ab...].

It doesn’t happen to everyone with ADHD, but the majority.

The effect itself was prominent/notable as early as WW1, as the drugs were widely used by all parties to help fight fatigue and drowsiness. However, a small percentage of the population would end up with the opposite effect - ending up tired, even sleepy, and often calmer instead of more alert.

It took awhile however, before wider implications of sub-population differences in drug effects like this were studied or applied.

Re:ADHD drug treatment and risk of negative events and outcomes by jakkos on Friday August 15, 2025 @09:00PM (#44919017)
> ADHD is kind of a weakly differentiated diagnosis that could apply to most people

I don't think this hypothesis would survive a look through the literature on google scholar. ADHD is associated with huge increases in risks of suicide, substance abuse, homelessness, accidents, crime, autoimmune disease, etc etc etc. It's not just "damn I find it hard to focus sometimes".

Re:ADHD drug treatment and risk of negative events and outcomes by mrlongroots on Friday August 15, 2025 @09:58PM (#44919421)
I have diagnosed ADHD and I agree largely with the person you are responding to.

The claim is not that ADHD is not a set of people with real psychiatric disorders, but it is a loose umbrella for what are actually disparate problems.

I recently learned that my symptoms, to a large extent, can be explained more accurately as POTS or something adjacent, and the meds I guided my psychiatrist towards were far more helpful than the stimulants I was being prescribed. This was a combination of me, reddit, and later LLMs arriving at me-specific diagnoses that go beyond clinical guideline regimes.

Re:ADHD drug treatment and risk of negative events and outcomes by jakkos on Saturday August 16, 2025 @06:48AM (#44922095)
> a loose umbrella for what are actually disparate problems

For me, the DSM-V & DIVA criteria are eerily accurate. I was diagnosed as an adult and it felt like a cruel cosmic joke reading through the psychiatrist report and realizing that most of my past and present issues were repeatedly-documented commonalities of a single condition. It was as if my life had just been playing out from a predetermined script.

I fully agree that that many distinct conditions are incorrectly swept under the "ADHD umbrella", but ADHD is not in any way a "loose" description of me.

> more helpful than the stimulants

My currently prescribed stimulants have been the only thing to ever make me feel consistently "okay", after having previously given up on medications ever helping. I'm sure they also enable me to write a few more lines of code per day, but I'd still be taking them even if they made me significantly worse at doing so.

Re:ADHD drug treatment and risk of negative events and outcomes by fossuser on Saturday August 16, 2025 @09:29AM (#44923230)
My criticism is not that the criteria don’t apply or that people don’t think they do - but that most people reading it seem to describe what you’re saying.

It seems more like a horoscope to me - everyone can find themselves in the criteria. It’s an observable thing, I’m just not sure I buy its special distinction.

People also used to make the claim that the stimulant drugs had special effects (or even opposite effects) on those with ADHD vs. the non ADHD population which always seemed like bullshit to me, but I don’t see that claim being made here anymore.

Edit: after writing this comments others in the thread started making this claim

Re:ADHD drug treatment and risk of negative events and outcomes by Jach on Saturday August 16, 2025 @12:56PM (#44925100)
I largely agree with you but it's not quite as generic as horoscopes and similar can be. Let's look at the DSM-V's diagnostic criteria for ADHD:

A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development, as characterized by (1) and/or (2). B. Several inattentive or hyperactive-impulsive symptoms were present prior to age 12 years. C. Several inattentive or hyperactive-impulsive symptoms are present in two or more settings (e.g. at home, school, or work; with friends or relatives; in other activities). D. There is clear evidence that the symptoms interfere with, or reduce the quality of, social, academic, or occupational functioning. E. The symptoms do not occur exclusively during the course of schizophrenia or another psychotic disorder and are not better explained by another mental disorder (e.g. mood disorder, anxiety disorder, dissociative disorder, personality disorder, substance intoxication or withdrawal).

I think E is probably a common miss, and fits with ADHD being over-diagnosed vs. other disorders that can have overlapping symptoms. The differential diagnosis section could perhaps be more detailed. But now briefly looking at A's (1) and (2). (1) Inattention: Six (or more) of the following symptoms have persisted for at least 6 months ... (lists 9 symptoms related to forms of inattention, the most generic of which I think is just f: "Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (e.g. schoolwork or homework; for older adolescents and adults, preparing reports, completing forms, reviewing lengthy papers)") (2) Hyperactivity and impulsivity: Six (or more) of the following symptoms .. (lists another 9 symptoms -- I count 3 pretty generic ones in a. (often fidgeting), f. (often talking excessively), and g. (often not waiting for a turn in conversation or completing people's sentences -- common in online meetings)).

While flawed I think this is enough detail to diagnose someone and clearly say "you're different", it's not nearly as broad as a horoscope "this sign is strong" or "that sign is deep" language and similar. The "Often" qualifier does a lot of work. Nevertheless, two people can both be diagnosed with "ADHD" and yet have few to no overlapping diagnostic symptoms.

Re:ADHD drug treatment and risk of negative events and outcomes by jakkos on Sunday August 17, 2025 @12:39AM (#44928906)
> It seems more like a horoscope to me - everyone can find themselves in the criteria. It’s an observable thing, I’m just not sure I buy its special distinction

Do you think the same about conditions like Autism or OCD?

People often say they "are a little bit" OCD or autistic, but it's the degree to which those traits are experienced which is the differentiation. There is also no objective test, it's all "soft" science.

> People also used to make the claim that the stimulant drugs had special effects (or even opposite effects) on those with ADHD vs. the non ADHD population

This is my experience, but I understand that anecdotes aren't good evidence.

Re:ADHD drug treatment and risk of negative events and outcomes by fossuser on Sunday August 17, 2025 @09:47AM (#44931518)
FWIW I don’t think the same about autism and OCD (at least not to the same extent). There are some similar problems with the soft diagnosis, but there is more going on there imo.

They both do have problems with variableness (particularly autism), but it’s more distinct from the general public.

Re:ADHD drug treatment and risk of negative events and outcomes by jakkos on Tuesday August 19, 2025 @12:16PM (#44953267)
My "personal hypothesis" is that the ADHD/Autism/OCD are fundamentally related somehow. The comorbidity between them is much higher than general population incidence, there's large symptom overlap, on a personal level I've found that I relate to and get on along much better with people who have at least one of those conditions, and a good 2/3rds of the people I consider close friends do.
Re:ADHD drug treatment and risk of negative events and outcomes by owkman on Saturday August 16, 2025 @12:55PM (#44925092)
What do you mean by POTS in this context? Postural orthostatic tachycardia syndrome? Would love to hear more
Re:ADHD drug treatment and risk of negative events and outcomes by mrlongroots on Saturday August 16, 2025 @04:58PM (#44926891)
Yep! A short summary of my n=1 findings (currently very speculative, but also sound I think, am meeting with my cardiologist next week to see what he thinks).

The type of ADHD I have seems to have an "autonomic nervous system impairment" component and a symptom profile overlapping with hyperadrenergic POTS.

1. I respond much better to Guanfacine ER (GFC) than stimulants alone (currently complementing with Vyvanse (LDX) 40mg, but I'd rate the Guanfacine as critical)

2. My blood pressure is very volatile, and GFC is supposed to have an impact but did not in my case, at least initially. I'd take GFC at bedtime and LDX in the morning, and on ChatGPT's suggestion, I asked my psych if I could take them together in the morning. Gamechanger for my blood pressure: the explanation seems to be that LDX makes my sympathetic nervous system extra simulated (on top of a poor baseline), and co-timed GFC balances it out.

3. I have poor cardiac endurance, and I find running nearly impossible. I'm a healthy young male who does weights and all. At ChatGPT's suggestion, I wore a Polar H10 and measured my resting heart rate while sitting, and then while standing still. I get a jump from 80bpm to 115bpm-ish, a strong indicator for something orthostatic.

I'm currently exploring rowing (with a concept2). I don't know why but it has a strong impact on my mental state that goes beyond general exercising: something about the rhythmic entrainment it produces, while being recumbent (good for POTS).

Re:ADHD drug treatment and risk of negative events and outcomes by matheusmoreira on Friday August 15, 2025 @09:50PM (#44919375)
Stimulants will stimulate anyone with a nervous system. It's just that ADHD patients will respond disproportionately well to the treatment, thereby justifying the risks.
Re:ADHD drug treatment and risk of negative events and outcomes by astrange on Saturday August 16, 2025 @01:11AM (#44920371)
Although "stimulate" is a bit misleading. They can calm you down if they stimulate the part of the brain responsible for calming you down more than the other parts.
Re:ADHD drug treatment and risk of negative events and outcomes by ttul on Friday August 15, 2025 @10:37PM (#44919638)
Your hypothesis is contracted by mountains of high quality scientific evidence. ADHD is a well-defined condition and there is an accepted way of diagnosing someone with it that effectively divides those with the condition from those without it. Stimulant medications may help many people to feel and be more productive, but that does not imply that people who meet the criteria for ADHD do not represent an identifiable group.

I highly encourage you to browse the Consensus Statement on ADHD, referenced below. It’s a compilation of 202 facts about ADHD, accepted by a global consensus of experts on ADHD.

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., Rohde, L. A., Yang, L., Cortese, S., Almagor, D., Stein, M. A., Albatti, T. H., Aljoudi, H. F., Alqahtani, M. M. J., Asherson, P., … Wang, Y. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence‑based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022

Re:ADHD drug treatment and risk of negative events and outcomes by thisislife2 on Saturday August 16, 2025 @12:10AM (#44920079)
> "high quality scientific evidence"

Mostly, unfortunately, funded by Pharmaceutical companies - ADHD Nation: Children, Doctors, Big Pharma, and the Making of an American Epidemic ( https://www.amazon.com/ADHD-Nation-Children-American-Epidemi... ):

> More than 1 in 7 American children get diagnosed with ADHD—three times what experts have said is appropriate—meaning that millions of kids are misdiagnosed and taking medications such as Adderall or Concerta for a psychiatric condition they probably do not have. The numbers rise every year. And still, many experts and drug companies deny any cause for concern. In fact, they say that adults and the rest of the world should embrace ADHD and that its medications will transform their lives.

Re:ADHD drug treatment and risk of negative events and outcomes by astrange on Saturday August 16, 2025 @01:10AM (#44920361)
Properly designed preregistered studies are credible even if they're funded by people you don't like. All medication in the US is approved by studies funded by the company that applies to be able to sell it. Who else would be motivated to study them?
Re:ADHD drug treatment and risk of negative events and outcomes by fossuser on Saturday August 16, 2025 @09:53AM (#44923453)
The diagnosis criteria in that consensus is pretty weak imo and part of the subjectivity I’m talking about.

They claim there are observable differences, but none of these alone can be used for diagnosis.

> The diagnosis of ADHD has been criticized as being subjective because it is not based on a biological test. This criticism is unfounded. ADHD meets standard criteria for validity of a mental disorder established by Robins and Guze (Faraone, 2005; 1970). The disorder is considered valid because: 1) well-trained professionals in a variety of settings and cultures agree on its presence or absence using well-defined criteria and 2) the diagnosis is useful for predicting a) additional problems the patient may have (e.g., difficulties learning in school); b) future patient outcomes (e.g., risk for future drug abuse); c) response to treatment (e.g., medications and psychological treatments); and d) features that indicate a consistent set of causes for the disorder (e.g., findings from genetics or brain imaging)

I don’t find this very persuasive and it’s a problem in the field generally.

Re:ADHD drug treatment and risk of negative events and outcomes by andoando on Saturday August 16, 2025 @10:25AM (#44923722)
Which part of the disgnosis do you find objective measures? There isnt a single scientific one

Take a look at studying looking at the consensus on diagnosis. Even among psychatrists the same patient gets diagnosed with different things.

Re:ADHD drug treatment and risk of negative events and outcomes by bruce343434 on Saturday August 16, 2025 @01:54PM (#44925541)
QbTest [https://www.qbtech.com/adhd-tests/qbtest/]

It measures your ability to focus your attention quite objectively and there's statistically significant differences between neurotypical and adhd performance. This test was used during my own diagnosis.

Re:ADHD drug treatment and risk of negative events and outcomes by andoando on Saturday August 16, 2025 @04:25PM (#44926635)
There is no doubt some differences in people who experienced mental problems, and sought or were given a diagnosis, and the general population.

QbTest was retroactively designed specifically to target this subjectively diagnosed ADHD group. This may be evidence that an ADHD diagnosis does differentiate populations based on some criteria, but it says nothing to this differentiation being caused by a singular disorder/pathology

I'd like to see a study of this test done on other comorbidities. I found this for example which finds a weak relation in these tests https://pubmed.ncbi.nlm.nih.gov/38317541/ differentiating between ADHD and depression, anxiety, OCD.

Here is another study. https://pubmed.ncbi.nlm.nih.gov/37800347/ >Conclusions: When used on their own, QbTest scores available to clinicians are not sufficiently accurate in discriminating between ADHD and non-ADHD clinical cases. Therefore, the QbTest should not be used as stand-alone screening or diagnostic tool, or as a triage system for accepting individuals on the waiting-list for clinical services. However, when used as an adjunct to support a full clinical assessment, QbTest can produce efficiencies in the assessment pathway and reduce the time to diagnosis.

I'll also point out few things:

1. Attention/focus is not a simple single metric one can measure and varies entirely on the task/situation at hand. That is a computerized test with no actual risk/reward to a person is not a predictor of attention/focus in general life. Focus/attention is driven largely by the feelings, rewards, risks, outcomes someone sees, those with diagnosed ADHD are already entering this study with an entirely different mental perception/attitude.

2. There is inherent bias present in ADHD patients in they may intentionally fudge their performance to meet their diagnosis. Unlike most disorders, people actually seek an ADHD diagnosis for access to stimulants, and its incredibly easy to understand how to mimic that behavior for these tests.

3. Other computerized tests have existed aiding in diagnosis, so this becomes circular.

Re:ADHD drug treatment and risk of negative events and outcomes by bruce343434 on Sunday August 17, 2025 @05:19AM (#44930130)
I think if you look hard enough there will always be fuzzy boundaries and overlaps in all the forms of neurodivergence. And yet, stereotypes and categories exist for a reason. Just because diagnosis is not perfect, doesn't mean it isn't good enough to do more good than harm in the world.

To your point 1, that's true. When there's ample motivation/inspiration, which is fickle and as far as I can tell not really up for conscious mutation, hyperfocus can occur in people with ADHD.

2: The test was actually quite long. In my unmedicated graph my attention was pretty high at first, but then I apparently got slowly distracted or disengaged. During the test I didn't feel distracted or disengaged however, and yet it showed quite clearly. Might it be harder than you think for people to "fake" this in a convincing way?

Anyway I do look forward to a better understanding of ADHD rather than "not enough dopamine" which seems to be the leading explanation. And I'm curious how much of a bimodal distribution that spectrum of dopamine deficiency is for humanity, or whether it is even bimodal at all.

Re:ADHD drug treatment and risk of negative events and outcomes by andoando on Sunday August 17, 2025 @12:50PM (#44932967)
What I am trying to say is that the brain is a VERY complex machine, I do not believe there is a singular cause for why people fail to be motivated/alert in their daily lives.

I refuse to call it ADHD, as that implies some known pathology. It is imo a social construction. Categorization can be useful for assessment/treatment but it isnt science. Quite frankly I dont care if people were handed amphetamines simply because they wanted to see if it improved their lives.

I will just say, I am disgnosed and take stims and the best and most motivatrd I ever felt was when I was doing some sort of physical activity almost daily, had a challenging rewarding job and friends. I was completely sober and happy, and completely depressed, ADHD like all the years prior. If youre not exercising regularly I highly suggest you try it

Re:ADHD drug treatment and risk of negative events and outcomes by ttul on Saturday August 16, 2025 @02:04PM (#44925637)
You’re right that there isn’t a _single_ “scientific” or purely objective test for ADHD. The consensus statements on ADHD make this explicit: diagnosis is clinical, not biomarker-based [1][2], even though biomarker tests are being developed and this is a promising area of research.

That said, there are structured and semi-objective tools that add quantifiable data to the process, even if they can’t stand alone; and, these tools in combination reveal a very real condition that is also highly treatable once diagnosed:

1. Rating scales (e.g. Vanderbilt, CBCL) use structured questionnaires to quantify symptom frequency. They’re subjective (based on parent/teacher/patient report) but standardized. Many mental health conditions are assessed using standardized rating scales [3].

2. Continuous Performance Tests (CPTs) and objective activity measures can quantify attention lapses and hyperactivity. They’re more “objective,” but consensus statements say they’re insufficient for diagnosis _in isolation_ [4]. I did a CPT test and it lit up for ADHD, which was helpful in ruling out other conditions.

3. Multi-informant reports (parents, teachers, patients) are required in good clinical practice to triangulate symptoms across contexts [5]. As I wrote in my first comment, ADHD exists only when the symptoms affect functioning in many areas of life.

4. Experimental methods (like neuroimaging or computerized neurocognitive tests) show promise but aren’t yet validated for clinical use [6].

The core of diagnosis remains a comprehensive clinical interview and history guided by DSM/ICD criteria. This is where “inter-rater variability” arises: different psychiatrists may weigh the same evidence differently. Consensus statements acknowledge this diagnostic variability, which is a limitation of current psychiatric nosology in general (not just ADHD).

So to answer directly: no, there isn’t a single objective test. But there are quantifiable tools that support diagnosis. The diagnosis itself is still fundamentally consensus- and criteria-driven, not biologically “proven.” But this limitation is minor and is common in psychiatry where many real conditions are diagnosed using a combination of approaches because no single test exists (and may never).

[1] Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J., Tannock, R., & Franke, B. (2021). The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022

[2] Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., & Nunes Filipe, C. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56, 14–34. https://doi.org/10.1016/j.eurpsy.2018.11.001

[3] Collett, B. R., Ohan, J. L., & Myers, K. M. (2003). Ten-Year Review of Rating Scales. V: Scales Assessing Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 42(9), 1015–1037. https://doi.org/10.1097/01.CHI.0000070245.24125.B6

[4] Hall, C. L., Valentine, A. Z., Groom, M. J., Walker, G. M., Sayal, K., Daley, D., & Hollis, C. (2016). The clinical utility of the Continuous Performance Test and Objective Measures of Activity for diagnosing and monitoring ADHD in children: A systematic review. European Child & Adolescent Psychiatry, 25(7), 677–699. https://doi.org/10.1007/s00787-015-0798-x

[5] American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

[6] Cao, Q., Zang, Y., Sun, L., Sui, M., Long, X., Zou, Q., & Wang, Y. (2006). Abnormal neural activity in children with attention deficit hyperactivity disorder: A resting-state functional magnetic resonance imaging study. NeuroReport, 17(10), 1033–1036. https://doi.org/10.1097/01.wnr.0000224769.92454.5d

Re:ADHD drug treatment and risk of negative events and outcomes by andoando on Saturday August 16, 2025 @04:39PM (#44926737)
1. Standardized is absolutely meaningless here. We can develop any set of symptoms, develop a standardized questionnaire, and have millions of people who meet it.

2. CPT measures attention/focus in an entirely made up lab scenario. Attention and focus are not singular numbers, and are deeply tied to the actual emotions, risks, rewards present in a situation, and cannot be so easily measured. I can see the value of a test that measures noticeable difference between two groups, but that says nothing about the cause of those differences, but simply that we can identify different groups of people. You may also very well be selecting here who are depressed, stressed, low energy, or simply people who see no point in spending energy on a completely meaningless task, etc. In any case, I do not believe the evidence of CPT in differentiation is well established. https://pubmed.ncbi.nlm.nih.gov/38317541/ https://pubmed.ncbi.nlm.nih.gov/37800347/

3. Personal reports of another person's mental state is as subjective as you can get. All were selecting here is people who do not fit the defined, artificially built, educational or work systems. One may even be excellent, motivated student of music but all accounts fail in a classroom setting.

>The core of diagnosis remains a comprehensive clinical interview and history guided by DSM/ICD criteria.

Clinical interviews are guided, and their interpretation is subjective.

DSM is as subjective as you can get. Every single on of the symptoms has the wording "Often", as decided by a person evaluating another person's account of their life. Do you have an objective measure of what "often" means?".

More importantly, a collection of symptoms does not constitute a singular cause. By the admission of the DSM itself, two people with the diagnosis can share only 4 out of the 9 symptoms (me 1-6, you 3,9), meaning every single one of the symptoms has independent causes. How do you know one does not simply have 6 symptoms by caused by entirely different factors? In a population of hundreds of millions, its a guarantee. You could again, define random symptoms, give it a name and have millions of people going "Wow, no way, I meet all of this, I didnt know I have xyz!"

Lastly, I find it really interesting is that the diagnosis of ADHD came far before we had any of this technology and research you point to. Why was it so popularly pushed and accepted then? Is it possible, were simply trying very hard to fit a completely socially agreed upon disorder?

Re:ADHD drug treatment and risk of negative events and outcomes by ttul on Monday August 18, 2025 @01:24AM (#44937668)
You've raised some common and valid criticisms of how ADHD is diagnosed.

1. On standardized scales being "meaningless": The term "standardized" here doesn't just mean a consistent set of questions. It means the scoring is normed against a large, representative population. So when a parent says their child "often" loses things, the scale helps a clinician determine if that "often" is statistically significant compared to other children of the same age and gender. It's a tool to quantify subjective reports. You're right that any set of symptoms can be standardized, but these scales are specifically designed to measure the frequency and severity of behaviors outlined in the DSM/ICD criteria. They aren't a standalone test, but one data point in a larger clinical picture. Most psychiatric conditions rely on this kind of structured self-reporting. The people working in this field work very hard to apply statistics properly when designing and running these tests; it's so far from random it's not even funny.

2. On CPTs: I agree that a CPT is an artificial lab scenario. That's a well-known limitation called a lack of "ecological validity." No one claims it perfectly replicates real-world focus. Consensus statements are clear that CPTs are insufficient for diagnosis on their own. Their value isn't in definitively saying "you have ADHD," but in providing an objective measure of things like attention lapses and impulse control that can supplement the subjective reports. If someone's self-report suggests severe inattention but they score perfectly on a CPT, that's a data point a clinician needs to investigate further. It can help in the process of differential diagnosis. The studies you linked highlight its limitations, which is consistent with the consensus view that it's a supplementary, not a primary, tool.

3. On multi-informant reports: You say these are "as subjective as you can get," which is true, they are subjective. The entire point is to gather subjective reports from multiple contexts to see if a pattern emerges. A core criterion for ADHD is that the symptoms cause impairment in two or more settings (e.g., home and school/work). If a child is only described as hyperactive and inattentive in a boring classroom but is a focused and motivated musician at home, a good clinician would question an ADHD diagnosis and look for other factors. The goal is to see if the problem is with the person's underlying regulation skills across environments, not just their "fit" in a single, artificial system.

4. On the DSM and clinical interviews: The word "often" is intentionally not given a hard number because it's relative to a person's developmental stage. "Often" losing homework is different for a 7-year-old than for a 30-year-old. This is where clinical judgment, guided by the DSM criteria, comes in. As for the symptom overlap, you're describing a feature of many polythetic diagnostic systems, not a flaw unique to ADHD. It recognizes that the disorder can manifest differently in different people. The clinician's job isn't just to count symptoms, but to assess the entire pattern, determine the level of impairment, and critically, rule out other potential causes for those symptoms (anxiety, depression, trauma, etc.). The diagnosis is a synthesis of all this information. Again, standardized test scoring DOES have the effect of giving a "definition" to the term "Often", because when thousands of forms are filled in, individuals' different definitions of the term converge in a statistically significant way onto a concept that is meaningfully comparative.

5. Finally, your historical point is interesting. Descriptions of ADHD-like symptoms date back centuries, long before the DSM. Sir Alexander Crichton wrote about "the incapacity of attending" in 1798. The diagnosis wasn't just invented out of thin air in the 20th century. It's a modern label for a pattern of behavior that has been observed for a very long time. The research and technology we have today are being used to better understand its neurobiological underpinnings, not to retroactively justify a "socially agreed upon disorder".

I'm really curious what the next century of study will do to illuminate this condition. I suspect we will have significantly greater understanding of the role of genetics and perhaps, one day, a blood test will diagnose ADHD.

Re:ADHD drug treatment and risk of negative events and outcomes by andoando on Monday August 18, 2025 @11:05AM (#44941449)
I hold the same criticism for other psychatrist disorders, I am only talking about ADHD because its the one I personally identify with and spent the most time thinking about.

I am not disputing that it's possible to group populations on behavioral traits, long standing emotional states, etc. If you want to say "there are people who feel unmotivated, inattentive in their life and we call that ADHD", fine. However identifying a distinctive cause as a scientific fact is an entirely different matter. I.e, your behavior catagorizes you as ADHD by the DSM is a very different statement than something like "you lose things often BECAUSE you have ADHD"

>but in providing an objective measure of things like attention lapses and impulse control that can supplement the subjective reports.

Stick in me an abstract math class and all my neurons will be firing, put me in accounting and ill fall asleep. How is a simplified messure of attention in a single artificial scenario interesting? These labs are for profit companies trying to make a buck.

>Again, standardized test scoring DOES have the effect of giving a "definition" to the term "Often",

I dont see how this follows. You at best merely have some distribution of how often people feel like they lose things. You have no way of either knowing how often it is people actually lose things or how inattentive they are in conversations, and certainly less so that the patient in front of you is so. I urge you to think about this little more deeply.

Lets take inattentive in conversations for a second. How many conversations does the patient have, with whom? What are the patient's interests versus the type of conversations they have? Are they shy, awkward, or likewise the people around them? How long of not paying attention is considered inattentive? What is the objectively measured norm for all these behaviors? And if you can admit its way too hard to measure, all youre doing is basing your decision on your own and your patients feelings. As a psychiatrist, you have to ask yourself, are you really trying to understand the cause of this patient's inattenttion in conversations, or are you merely looking enough evidence to fit them into a bucket that you already understand?

And this is besides my greater point here. Per the DSM, it is possible for you to have ADHD and not be found to be inattentive in conversations but often be losing your keys, and for me, vice versa. So eere admitting these things can have other factors. For example, I may be losing things simply because my mom never had me clean up after myself and I keep dirty place with too many visual distractions. Maybe I have a job or friends or whatever circumstances that make my life more chaotic. Perhaps going out anywhere makes me nervous so I don't think clearly about grabbing the things I need on the way out. Perhaps Im not as bothered by being inconvenienced so I dont care as much to meticulously think about the things I need.

And you will say "true, but ADHD isnt just losing your keys, its a pattern of related behaviors", and I say what is the belief that these different behaviors aren't independent?

Categorization can be useful, but by definition are loss of information. We have learned nothing by attaching a name, except perhaps a feeling that we have something simple we can understand.

Re:ADHD drug treatment and risk of negative events and outcomes by pygy_ on Saturday August 16, 2025 @02:17AM (#44920707)
I don't know if the evidence is more than anecdotal, but I've read that ADHD smokers who are taking adderal have to increase the dose of their treatment to remain functional when they quit smoking.

I've been taking nicotine patches for half a year now, with great success (and it is available OTC unlike other stimulants). Nicotine in itself isn't toxic at these doses (7, 14, 21mg), it's a cool life hack :-).

Re:ADHD drug treatment and risk of negative events and outcomes by fossuser on Saturday August 16, 2025 @12:54PM (#44925084)
I enjoy cigars and notice the positive effect, my fear with the patches or Lucy/zyn is that it not being self limiting seems to lead to people having one in their lip literally every waking minute when they’re not eating.
Re:ADHD drug treatment and risk of negative events and outcomes by pygy_ on Saturday August 16, 2025 @04:44PM (#44926777)
Patches are changed once per day, and their pharmacokinetics isn't addictive (the nicotine blood levels rise too slowly to give you a dopamine boost).

I sometimes realize in the afternoon that I forgot to change my patch in the morning because I'm a bit drowsy (a feeling not unlike being uncaffeinated when you're used to drinking coffee). AFAIK the withdrawal symptoms fade out in at most a week.

Re:ADHD drug treatment and risk of negative events and outcomes by Llamamoe on Saturday August 16, 2025 @03:50AM (#44921198)
> and ADHD is kind of a weakly differentiated diagnosis that could apply to most people.

It's not, the problem is that it sounds like it because ~everyone faces some (way) lesser version of the struggles ADHD people face literally every day, many of whom probably do have some subclinical degree of executive dysfunction.

My personal thumb rule is that somebody is capable of finishing school, autonomously managing their living conditions, finding and keeping a job, and having at least a modicum of social life at the same time, they're high-functioning enough that they almost definitely don't have ADHD, or only some ultra-light version of it.

Re:ADHD drug treatment and risk of negative events and outcomes by kayodelycaon on Saturday August 16, 2025 @09:09AM (#44923075)
High-functioning doesn’t mean you’re not suffering horribly every single day. It can mean you’re a strong willed and good at masking.

I was “functional” through a four month long psychotic break in which I was constantly one mistake from people finding out I wasn’t human and killing me. (I’m fine now. No lasting trauma fortunately.)

How someone looks from the outside isn’t a good measure of their mental health. How many people have been depressed and killed themselves without any obvious warnings?

Re:ADHD drug treatment and risk of negative events and outcomes by rwyinuse on Saturday August 16, 2025 @02:40PM (#44925881)
The problem with your rule of thumb is that there can be lots of external factors at play. Like, what if the person happens to be deeply gifted and/or interested in some school subjects, allowing hyperfocus on them? What if there is major external pressure pushing them to take care of their home, do well at school etc?

I think ADHD is a spectrum, which includes those with "ultra-light" symptoms as well. Whether those in the lower-end of the spectrum need stimulant medication is a different matter.

Re:ADHD drug treatment and risk of negative events and outcomes by NegativeK on Saturday August 16, 2025 @03:17PM (#44926175)
I grew up with this belief (not your belief; it's a common one) and it hindered me from realizing I needed help.

I regularly have people doubt my diagnosis to this day. If we talk about it more, a lot of them _continue_ to doubt me even after I explain masking.

Again, it's not just your belief -- I grew up hearing radio jockeys calling ADHD "bad parenting disease" -- but this belief is harmful. It ostracizes people and discourages help for a disability that causes measurable harm.

Re:ADHD drug treatment and risk of negative events and outcomes by pas on Sunday August 17, 2025 @03:45PM (#44934334)
> that could apply to most people

what does that mean? most people have more than 99% identical genes yet we are not clones.

most people don't have a perfect BMI of 23.5 (or whatever is the middle), yet there are clear pathologies on the BMI spectrum, no?

most people could better manage their lives and emotions but most people don't have that severe problems.

the usual diagnostic criteria simply does not apply for most people. the cutoff is pretty high. (problems in multiple spheres of life present before the age of ~14 -- though there's brain damage induced ADHD too)

but of course most people would benefit from some of the ADHD management strategies (which is better time management, planning, organizing things and consistently putting them into their assigned place, cognitive reframing of pervasive bad thoughts, getting a coach, etc.), but at the same time most people would not benefit from being on the usual ADHD meds (maybe they would benefit from some much smaller doses)